Article Information
vol. 8 no. 335 335ra56
- Received for publication October 29, 2015
- Accepted for publication April 1, 2016
Author Information
- Lishuang Cao1,*,
- Aoibhinn McDonnell1,*,
- Anja Nitzsche1,*,
- Aristos Alexandrou1,
- Pierre-Philippe Saintot1,
- Alexandre J.C. Loucif1,
- Adam R. Brown1,
- Gareth Young1,
- Malgorzata Mis2,
- Andrew Randall3,
- Stephen G. Waxman4,
- Philip Stanley1,
- Simon Kirby1,
- Sanela Tarabar5,
- Alex Gutteridge1,
- Richard Butt1,
- Ruth M. McKernan1,
- Paul Whiting1,
- Zahid Ali1,†,
- James Bilsland1,†,‡ and
- Edward B. Stevens1,†,‡
- 1Pfizer Neuroscience and Pain Research Unit, The Portway Building, Granta Park, Cambridge CB21 6GS, UK.
- 2University of Bristol, School of Physiology, Pharmacology, and Neuroscience, Bristol BS8 1TD, UK.
- 3Hatherly College of Life and Environmental Sciences, University of Exeter, Prince of Wales Road, Exeter EX4 4PS, UK.
- 4Yale Center for Neuroscience and Regeneration Research, Veterans Affairs Medical Center, 950 Campbell Avenue, Building 34,West Haven, CT 06516, USA.
- 5Pfizer, 1 Howe Street, New Haven, CT 06511, USA.
- ↵‡Corresponding author. E-mail: j.bilsland{at}ucl.ac.uk (J.B.); edward.stevens{at}pfizer.com (E.B.S.)